View by Specialty

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

Diabetes News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 30, 2024
3 min watch
Save

VIDEO: Hybrid Complete Health Improvement Program feasible for patients with type 2 diabetes

VIDEO: Hybrid Complete Health Improvement Program feasible for patients with type 2 diabetes

ORLANDO — A pilot study found a hybrid online/in-person version of the Complete Health Improvement Program could be feasible for patients with type 2 diabetes, according to a poster presented at the Lifestyle Medicine Conference.

SPONSORED CONTENT
October 29, 2024
3 min read
Save

‘This is the foundation’: New guideline emphasizes lifestyle-first approach to diabetes

‘This is the foundation’: New guideline emphasizes lifestyle-first approach to diabetes

ORLANDO — A first-ever clinical practice guideline from the American College of Lifestyle Medicine outlines practical recommendations for lifestyle interventions as first-line therapy for people with prediabetes or type 2 diabetes.

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

SPONSORED CONTENT
October 25, 2024
3 min read
Save

Many people with ultraprocessed food addiction not identified as needing treatment

Many people with ultraprocessed food addiction not identified as needing treatment

BOSTON — Addiction to ultraprocessed food may be diagnosed similarly to other substance use disorders, and reducing stigma and tailored treatment are both important to improving cardiometabolic health, a speaker reported.

SPONSORED CONTENT
October 24, 2024
2 min read
Save

Semaglutide linked to reduced risk for Alzheimer’s in patients with diabetes

Semaglutide linked to reduced risk for Alzheimer’s in patients with diabetes

In patients with type 2 diabetes, semaglutide was associated with a significantly lower risk for an Alzheimer’s disease diagnosis within 3 years compared with other diabetes medications, according to a study published in Alzheimer’s & Dementia.

SPONSORED CONTENT
October 23, 2024
1 min read
Save

Top in endocrinology: GLP-1s may reduce suicide risk; type 2 diabetes after COVID-19

Top in endocrinology: GLP-1s may reduce suicide risk; type 2 diabetes after COVID-19

Adolescents prescribed a GLP-1 receptor agonist for obesity treatment reportedly had lower risk for suicidal thoughts and suicide attempts , according to researchers.

SPONSORED CONTENT
October 23, 2024
3 min read
Save

GLP-1, SGLT2 prescriptions for type 1 diabetes rising despite no regulatory approval

GLP-1, SGLT2 prescriptions for type 1 diabetes rising despite no regulatory approval

Prescriptions for GLP-1 receptor agonists and SGLT2 inhibitors for patients with type 1 diabetes rose between 2010 and 2023 despite not being approved for that population, according to a research letter published in JAMA.

SPONSORED CONTENT
October 22, 2024
3 min read
Save

Low-carb diet may benefit beta-cell function in patients with type 2 diabetes

Low-carb diet may benefit beta-cell function in patients with type 2 diabetes

Patients with type 2 diabetes on a carbohydrate-restricted diet showed recovery in beta-cell function, researchers reported in The Journal of Clinical Endocrinology & Metabolism.

SPONSORED CONTENT
October 21, 2024
1 min read
Save

Oral semaglutide prevents CV events in people with diabetes and heart disease, CKD

Oral semaglutide prevents CV events in people with diabetes and heart disease, CKD

Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.

SPONSORED CONTENT
October 17, 2024
4 min read
Save

Speakers highlight 2024 regulatory moves in hypertension, lipid, diabetes therapies

Speakers highlight 2024 regulatory moves in hypertension, lipid, diabetes therapies

There have been many recent regulatory updates in the areas of blood pressure management, dyslipidemia and diabetes management, speakers reported.

SPONSORED CONTENT
October 17, 2024
2 min read
Save

Drugs for diabetes, weight loss may also help treat substance use disorders

Drugs for diabetes, weight loss may also help treat substance use disorders

Ozempic and similar drugs for diabetes and weight-related conditions were associated with a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication in people with opioid and alcohol use disorders, a new study showed.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails